Searched for
GLAND PHARMA BLOCK DEAL NEWS
Fidelity Investments buys 2 pc stake in Lodha Developers for Rs 1,864 croreFidelity Investments has strategically acquired a 2% stake in Lodha Developers, amounting to Rs 1,864 crore, through open market operations...- Drone startup Elroy Air to list on Nasdaq via $1 billion SPAC dealCargo drone startup Elroy Air is set to go public in the US through a $1 billion merger with blank-check firm Columbus Circle Capital Corp ...
- Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...
- After quakes, Venezuela must unblock social media access: UN expertsUN experts are urging Venezuela to immediately restore access to social media and news outlets following devastating twin earthquakes. The ...
- Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
- Honasa Consumer to buy 58% stake in Fluence Pharma at Rs 135-crore enterprise valueMamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Promoter Twin Star sells Vedanta shares worth Rs 1,896 crore in block dealTwin Star Holdings, a promoter entity of Vedanta, sold 6.51 crore shares worth nearly Rs 1,896 crore through a block deal on Tuesday. The t...
- Honasa Consumer enters nutraceuticals segment; to acquires 58 pc stake in Fluence PharmaHonasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...
- Vedanta Power, Oil & Gas, and Iron shares rally up to 5%; Aluminium sheds 3%. Should you buy, sell or hold?Vedanta’s newly demerged entities extended their rally, with Oil & Gas, Power and Iron & Steel hitting upper circuits, while Aluminium slip...
- Block deal alert! Craftsman Auto shares in focus as promoter to sell stake worth Rs 486 croreCraftsman Automation shares are under scrutiny as promoter Srinivasan Ravi plans to sell up to 2.01% stake via a block deal worth Rs 486 cr...
- Stocks in news: TCS, JSW Infra, Craftsman Automation, IIFL Finance, Transrail LightingIndian markets showed a positive trend on Monday, recovering some of Friday's dips, buoyed by global sentiment and strong performance in th...
- Aurobindo Pharma US gets FTC nod for $250 million acquisition of Lannett CompanyAurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transactionIndia's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash...
- Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 crGlobal investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a ...
- Trump Iran deal full text, key highlights, clauses: What is in it?Trump Iran deal includes key issues such as the reopening of Strat of Hormuz and nuclear weapons sanctions.
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
Load More
